PROCEPT BioRobotics to Present at Upcoming 36th Annual Piper Sandler Healthcare Conference on December 4, 2024
Rhea-AI Summary
PROCEPT BioRobotics (Nasdaq: PRCT), a surgical robotics company specializing in urological solutions, has announced its participation in the 36th Annual Piper Sandler Healthcare Conference in New York City. The management team will deliver a presentation on Wednesday, December 4 at 8:30 a.m. Eastern Time.
The presentation will be accessible through a live webcast on the company's investor relations website. Interested parties can access the webcast recording for up to 90 days after the event through the company's website at https://ir.procept-biorobotics.com.
Positive
- None.
Negative
- None.
SAN JOSE, Calif., Nov. 26, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced that members of management will present at the upcoming 36th Annual Piper Sandler Healthcare Conference in New York City. Management is scheduled to present on Wednesday, December 4 at 8:30 a.m. Eastern Time.
A live webcast of each event, as well as an archived recording, will be available on the “Investors” section of the company’s website at: https://ir.procept-biorobotics.com. The webcasts will be archived and available for replay for at least 90 days after the event.
About PROCEPT BioRobotics Corporation
PROCEPT BioRobotics is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The HYDROS™ Robotic System is the only AI-Powered, robotic technology that delivers Aquablation therapy. PROCEPT BioRobotics designed Aquablation therapy to deliver effective, safe, and durable outcomes for males suffering from lower urinary tract symptoms or LUTS, due to BPH that are independent of prostate size and shape or surgeon experience. BPH is the most common prostate disease and impacts approximately 40 million men in the United States. The Company has developed a significant and growing body of clinical evidence with over 150 peer-reviewed publications, supporting the benefits and clinical advantages of Aquablation therapy.
Investor Contact:
Matt Bacso
VP, Investor Relations and Business Operations
m.bacso@procept-biorobotics.com
FAQ
When is PROCEPT BioRobotics (PRCT) presenting at the Piper Sandler Healthcare Conference?
How long will the PRCT Piper Sandler Conference webcast be available for replay?
Where can I watch PROCEPT BioRobotics' (PRCT) Piper Sandler Conference presentation?
Which healthcare conference is PROCEPT BioRobotics (PRCT) attending in December 2024?
